You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 22, 2024

~ Buy the ARISTADA INITIO KIT (aripiprazole lauroxil) Drug Profile, 2024 PDF Report in the Report Store ~

CLINICAL TRIALS PROFILE FOR ARISTADA INITIO KIT

✉ Email this page to a colleague

« Back to Dashboard

All Clinical Trials for ARISTADA INITIO KIT

Subscribe to access the full database, or Subscribe
Trial ID	Title	Status	Sponsor	Phase	Start Date	Summary
NCT03345979 ↗	A Study of Aripiprazole Lauroxil or Paliperidone Palmitate for the Treatment of Schizophrenia	Completed	Alkermes, Inc.	Phase 3	2017-11-15	This study will evaluate the efficacy of initiating treatment of schizophrenia with ARISTADA INITIO plus 30 mg oral aripiprazole followed by a 2-month dose of AL.
NCT04203056 ↗	Aripiprazole Lauroxil for Preventing Psychotic Relapse After an Initial Schizophrenia Episode	Recruiting	Alkermes, Inc.	Phase 4	2019-12-16	This 12-month study will evaluate the efficacy of aripiprazole lauroxil compared to oral aripiprazole in preventing the re-emergence of psychotic symptoms in patients with a recent onset of schizophrenia.
NCT04203056 ↗	Aripiprazole Lauroxil for Preventing Psychotic Relapse After an Initial Schizophrenia Episode	Recruiting	University of California, Los Angeles	Phase 4	2019-12-16	This 12-month study will evaluate the efficacy of aripiprazole lauroxil compared to oral aripiprazole in preventing the re-emergence of psychotic symptoms in patients with a recent onset of schizophrenia.
>Trial ID	>Title	>Status	>Sponsor	>Phase	>Start Date	>Summary

Clinical Trial Conditions for ARISTADA INITIO KIT

Condition Name

Chart
Table

Condition Name for ARISTADA INITIO KIT
Intervention	Trials
Schizophrenia	2
Schizophreniform Disorder	1
Schizoaffective Disorder, Depressive Type	1
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Condition MeSH

Chart
Table

Condition MeSH for ARISTADA INITIO KIT
Intervention	Trials
Schizophrenia	2
Depressive Disorder	1
Depression	1
Psychotic Disorders	1
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Locations for ARISTADA INITIO KIT

Trials by Country

Map
Table

Trials by Country for ARISTADA INITIO KIT
Location	Trials
United States	10
This preview shows a limited data set Subscribe for full access, or try a Trial

Trials by US State

Map
Table

Trials by US State for ARISTADA INITIO KIT
Location	Trials
California	2
Texas	1
New Jersey	1
Nevada	1
Missouri	1
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Progress for ARISTADA INITIO KIT

Clinical Trial Phase

Chart
Table

Clinical Trial Phase for ARISTADA INITIO KIT
Clinical Trial Phase	Trials
Phase 4	1
Phase 3	1
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Status

Chart
Table

Clinical Trial Status for ARISTADA INITIO KIT
Clinical Trial Phase	Trials
Recruiting	1
Completed	1
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Sponsors for ARISTADA INITIO KIT

Sponsor Name

Chart
Table

Sponsor Name for ARISTADA INITIO KIT
Sponsor	Trials
Alkermes, Inc.	2
University of California, Los Angeles	1
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Sponsor Type

Chart
Table

Sponsor Type for ARISTADA INITIO KIT
Sponsor	Trials
Industry	2
Other	1
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.